What one share of Disc Medicine holds
We are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. We have assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
Disc Medicine’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$6.56 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$5.27 |
| Cash and investments | $18.72 |
| Debt | $1.55 |
| Book value | $16.80 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$40.95 | $0.08 | −$31.42 | — | −$70.60 |
| 2022 | — | −$45.05 | $0.15 | −$40.79 | — | — |
| 2023 | — | −$3.42 | $0.00 | −$3.30 | — | $14.17 |
| 2024 | — | −$3.96 | $0.02 | −$3.42 | — | $14.85 |
| 2025 | — | −$6.01 | $0.03 | −$5.14 | — | $19.53 |
Common questions about Disc Medicine
How much does one share of Disc Medicine earn?
Over the last 12 months, Disc Medicine lost $6.56 for each share.
Does Disc Medicine pay a dividend?
Disc Medicine didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Disc Medicine’s book value per share?
Disc Medicine’s book value is $16.80 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Disc Medicine have?
Each share of Disc Medicine has $18.72 of cash and investments and $1.55 of debt, as of June 30, 2026.
What is Disc Medicine’s free cash flow per share?
−$5.27 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Disc Medicine bought back shares?
Disc Medicine’s share count rose about 3918% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.